Showing results (51-60 of 221) with videos related to
Sort By:
Pageof 23
Journal of Virology|April 1, 2021
Pre-existing T Cell Memory against Zika VirusBlake Schouest, Alba Grifoni, John Pham, et al.Cytometry. Part a : the Journal of the International Society for Analytical Cytology|April 18, 2018
DAFi: A directed recursive data filtering and clustering approach for improving and interpreting data clustering identification of cell populations from polychromatic flow cytometry dataAlexandra J Lee, Ivan Chang, Julie G Burel, et al.Frontiers in Immunology|March 29, 2021
Immune Memory in Mild COVID-19 Patients and Unexposed Donors Reveals Persistent T Cell Responses After SARS-CoV-2 InfectionAsgar Ansari, Rakesh Arya, Shilpa Sachan, et al.Pathogens (Basel, Switzerland)|January 28, 2026
Peptide MegaPools Approach to Evaluate the Dengue-Specific CD4 and CD8 T-Cell ResponseMarta Tiberi, Linda Petrone, Andrea Salmi, et al.Cell Host & Microbe|August 6, 2022
Immunological memory to common cold coronaviruses assessed longitudinally over a three-year period pre-COVID19 pandemicEsther Dawen Yu, Tara M Narowski, Eric Wang, et al.Biorxiv : the Preprint Server for Biology|March 9, 2022
Immunological memory to Common Cold Coronaviruses assessed longitudinally over a three-year periodEsther Dawen Yu, Tara M Narowski, Eric Wang, et al.BMC Medicine|January 30, 2026
Ocular light and optical radiation exposure as a modifiable environmental determinant of health: expert consensus on research gaps and prioritiesManuel Spitschan, Anna M Biller, Kai Broszio, et al.Human Immunology|May 5, 2011
Post-thymic regulation of CD5 levels in human memory T cells is inversely associated with the strength of responsiveness to interleukin-15Dietmar Herndler-Brandstetter, Stefan Brunner, Daniela Weiskopf, et al.Science Immunology|June 19, 2021
Activation of mTORC1 at late endosomes misdirects T cell fate decision in older individualsJun Jin, Chulwoo Kim, Qiong Xia, et al.Vaccine|September 19, 2023
A measles virus-based vaccine induces robust chikungunya virus-specific CD4<sup>+</sup> T-cell responses in a phase II clinical trialKatharina S Schmitz, Anouskha D Comvalius, Nella J Nieuwkoop, et al.Pageof 23